Patents by Inventor Tammy Louise Kalber

Tammy Louise Kalber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liposome nanoparticles for tumor magnetic resonance imaging
    Patent number: 11369697
    Abstract: The present invention provides novel liposomes comprising Gd.DOTA.DSA (gadolinium (III) 2-{4,7-bis-carboxymethyl-10-[(N,N-distearylamidomethyl-N?-amido-methyl]-1,4,7,10- =tetra-azacyclododec-1-yl}-acetic acid), characterised in that the liposome further comprises a neutral, fully saturated phospholipid component (e.g. DSPC (1,2-distearoyl-sn-glycero-3-phospocholine]), which are of particular use in the preparation of magnetic resonance contrast agents for enhancing a magnetic resonance image of tumours in a mammal.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: June 28, 2022
    Assignees: UNITED KINGDOM RESEARCH AND INNOVATION, IMPERIAL INNOVATIONS LIMITED
    Inventors: Nazila Kamaly, Tammy Louise Kalber, Gavin David Kenny, Maya Thanou, Andrew David Miller, Jimmy David Bell
  • Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging
    Publication number: 20170348440
    Abstract: The present invention provides novel liposomes comprising Gd.DOTA.DSA (gadolinium (III) 2-{4,7-bis-carboxymethyl-10-[(N,N-distearylamidomethyl-N?-amido-methyl]-1,4,7,10-tetra-azacyclododec-1-yl}-acetic acid), characterised in that said liposome further comprises a neutral, fully saturated phospholipid component (e.g. DSPC (1,2-distearoyl-sn-glycero-3-phospocholine]), which are of particular use in the preparation of magnetic resonance contrast agents for enhancing a magnetic resonance image of tumours in a mammal.
    Type: Application
    Filed: March 20, 2017
    Publication date: December 7, 2017
    Applicants: Medical Research Council, Imperial Innovations Limited
    Inventors: Nazila KAMALY, Tammy Louise KALBER, Gavin David KENNY, Maya THANOU, Andrew David MILLER, Jimmy BELL
  • Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging
    Publication number: 20130129636
    Abstract: The present invention provides novel liposomes comprising Gd.DOTA.DSA (gadolinium(III)2-{4,7-bis-carboxymethyl-10-[(N,N-distearylamidomethyl-N?-amido-methyl]-1,4,7,10-tetra-azacyclododec-1-yl}-acetic acid), characterised in that said liposome further comprises a neutral, fully saturated phospholipid component (e.g. DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine]), which are of particular use in the preparation of magnetic resonance contrast agents for enhancing a magnetic resonance image of tumours in a mammal.
    Type: Application
    Filed: November 19, 2010
    Publication date: May 23, 2013
    Applicants: IMPERIAL INNOVATIONS LIMITED, MEDICAL RESEARCH COUNCIL
    Inventors: Nazila Kamaly, Tammy Louise Kalber, Gavin David Kenny, Maya Thanou, Andrew David Miller, Jimmy Bell